SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-059778
Filing Date
2012-11-06
Accepted
2012-11-06 17:03:02
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v326291_10q.htm 10-Q 322071
2 EXHIBIT 10.2 v326291_ex10-2.htm EX-10.2 374092
3 EXHIBIT 31.1 v326291_ex31-1.htm EX-31.1 9117
4 EXHIBIT 31.2 v326291_ex31-2.htm EX-31.2 9122
5 EXHIBIT 32.1 v326291_ex32-1.htm EX-32.1 4166
  Complete submission text file 0001144204-12-059778.txt   3587418

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvlt-20120930.xml EX-101.INS 378027
7 XBRL TAXONOMY EXTENSION SCHEMA nvlt-20120930.xsd EX-101.SCH 39176
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvlt-20120930_cal.xml EX-101.CAL 34818
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvlt-20120930_def.xml EX-101.DEF 165979
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvlt-20120930_lab.xml EX-101.LAB 308266
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvlt-20120930_pre.xml EX-101.PRE 205145
Mailing Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458
Business Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458 617-244-1616
NOVELOS THERAPEUTICS, INC. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-119366 | Film No.: 121183949
SIC: 2834 Pharmaceutical Preparations